Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28.9M
-
Number of holders
-
196
-
Total 13F shares, excl. options
-
26.4M
-
Shares change
-
+401K
-
Total reported value, excl. options
-
$705M
-
Value change
-
+$9.1M
-
Put/Call ratio
-
0.28
-
Number of buys
-
100
-
Number of sells
-
-91
-
Price
-
$26.65
Significant Holders of CASTLE BIOSCIENCES INC - Common Stock (CSTL) as of Q4 2024
235 filings reported holding CSTL - CASTLE BIOSCIENCES INC - Common Stock as of Q4 2024.
CASTLE BIOSCIENCES INC - Common Stock (CSTL) has 196 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.4M shares
of 28.9M outstanding shares and own 91.46% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (2.92M shares), VANGUARD GROUP INC (1.83M shares), WASATCH ADVISORS LP (1.8M shares), PRINCIPAL FINANCIAL GROUP INC (1.44M shares), DIMENSIONAL FUND ADVISORS LP (999K shares), CITADEL ADVISORS LLC (835K shares), UBS Group AG (813K shares), Portolan Capital Management, LLC (777K shares), Bellevue Group AG (746K shares), and WELLINGTON MANAGEMENT GROUP LLP (722K shares).
This table shows the top 196 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.